SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-21-020014
Filing Date
2021-06-07
Accepted
2021-06-07 08:07:15
Documents
7
Period of Report
2021-06-07
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10025493_8k.htm 8-K 26569
2 EXHIBIT 10.1 brhc10025493_ex10-1.htm EX-10.1 27608
3 EXHIBIT 10.2 brhc10025493_ex10-2.htm EX-10.2 62226
4 EXHIBIT 99.1 brhc10025493_ex99-1.htm EX-99.1 16252
5 image0.jpg GRAPHIC 631
6 image00002.jpg GRAPHIC 7406
7 image00003.jpg GRAPHIC 60607
  Complete submission text file 0001140361-21-020014.txt   228759
Mailing Address 11975 EL CAMINO REAL, STE 101 SAN DIEGO CA 92130
Business Address 11975 EL CAMINO REAL, STE 101 SAN DIEGO CA 92130 8582994699
Kinnate Biopharma Inc. (Filer) CIK: 0001797768 (see all company filings)

IRS No.: 824566526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39743 | Film No.: 21998302
SIC: 2834 Pharmaceutical Preparations